低收入未参保女性宫颈癌前病变与癌症风险及2019风险指南适用性
研究分析2009至2017年美国CDC国家乳腺癌和宫颈癌早期检测项目中363,546名低收入未参保或保险不足女性的宫颈筛查与随访数据,采用患病率-发病率混合模型估计HPV与细胞学各结果组合的即时应风险。结果显示筛查及时者的CIN3+风险与Kaiser Permanente Northern California数据相似,而从未筛查或未及时筛查者风险更高。2019风险基于管理指南适用于筛查及时的低收入未参保女性。
要点
- 筛查及时的低收入未参保女性CIN3+即时应风险与指南制定人群相似。
- 从未筛查或未及时筛查者CIN3+即时应风险更高。
- HPV阳性伴高级别细胞学、从未筛查或未及时筛查者建议立即治疗。
核心结论
- 2019宫颈风险基于管理指南适用于筛查及时的低收入未参保和保险不足女性。
- 从未筛查或未及时筛查的女性CIN3+即时应风险更高。
- HPV阳性伴高级别细胞学、从未筛查或未及时筛查者被管理指南推荐立即治疗。
研究设计与样本
- 分析2009至2017年CDC国家乳腺癌和宫颈癌早期检测项目中363,546名女性的宫颈筛查与随访数据。
- 采用患病率-发病率混合模型估计CIN3或癌症的即时应风险(患病风险)。
- 按HPV与细胞学结果各组合及筛查史分层估计风险,并与风险基于管理指南所用已发表估计比较。
主要发现
- 筛查及时(过去5年内细胞学筛查)的女性CIN3+即时应风险与Kaiser Permanente Northern California女性相似。
- 从未筛查或未及时筛查的女性CIN3+即时应风险更高。
关键数值与推荐
- 筛查及时定义为过去5年内接受细胞学筛查。
临床怎么用
- 对筛查及时的低收入未参保女性可沿用2019风险基于管理指南。
- 对HPV阳性伴高级别细胞学、从未筛查或未及时筛查的女性应考虑立即治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: New guidelines for managing cervical precancer among women in the United States use risk directly to guide clinical actions for individuals who are being screened. These risk-based management guidelines have previously only been based on risks from a large integrated healthcare system. We present here data representative of women of low income without continuous insurance coverage to inform the 2019 guidelines and ensure applicability. OBJECTIVE: We examined the risks of high-grade precancer after human papillomavirus and cytology tests in underserved women and assessed the applicability of the 2019 guidelines to this population. STUDY DESIGN: We examined cervical cancer screening and follow-up data among 363,546 women enrolled in the Centers for Disease Control and Prevention's National Breast and Cervical Cancer Early Detection Program from 2009 to 2017. We estimated the immediate (prevalent) risks of cervical intraepithelial lesion grade 3 or cancer by using prevalence-incidence mixture models. Risks were estimated for each combination of human papillomavirus and cytology result and were stratified by screening history. We compared these risks with published estimates used in new risk-based management guidelines. RESULTS: Women who were up-to-date with their screening, defined as being screened with cytology within the past 5 years, had immediate risks of cervical intraepithelial neoplasia grade 3 or higher similar to that of women at Kaiser Permanente Northern California, whose data were used to develop the management guidelines. However, women in the Centers for Disease Control and Prevention's National Breast and Cervical Cancer Early Detection Program had greater immediate risks if they were never screened or not up-to-date with their screening. CONCLUSION: New cervical risk-based management guidelines are applicable for underinsured and uninsured women with a low income in the United States who are up-to-date with their screening. The increased risk observed here among women who received human papillomavirus-positive, high-grade cytology results, who were never screened, or who were not up-to-date with their cervical cancer screening, led to a recommendation in the management guidelines for immediate treatment among these women.
引用
- Saraiya M, Cheung LC, Soman A, et al. Risk of cervical precancer and cancer among uninsured and underserved women from 2009 to 2017. Am J Obstet Gynecol. 2020. PMID: 33035473. doi:10.1016/j.ajog.2020.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。